PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Tramadol hydrochloride - Pain (Neuropathic)
PAD Profile : Tramadol hydrochloride - Pain (Neuropathic) Important
Keywords :
neuropathic pain, diabetic neuropathy, postherpetic neuralgia, PHN
Brand Names Include :
Marol
Important Information :
NICE CG 173 Consider tramadol only if acute rescue therapy is needed. Prescribe a short course (2-4 weeks on an acute script) and review at least every 3 months.
Traffic Light Status
Status 1 of 2.
Status :
Green (see narrative)
Formulations :
- Capsules
- Soluble tablets
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Status 2 of 2.
Status :
Green (see narrative)
Important
Formulations :
- Modified release capsules
- Modified release tablets
Important Information :
MR preparations to be prescribed by brand. Marol MR tablets are the locally preferred brand for primary care.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Guidelines
No guidelines returned.
Other Drugs
- Duloxetine
- Amitriptyline hydrochloride
- Gabapentin
- Pregabalin
- Nortriptyline
- Imipramine hydrochloride
- Dosulepin hydrochloride
- Capsaicin
Other Indications
Additional Documents
Type
Document
Review Date
Committee Recommendations
Date
Committee Name
Narrative
07 October 2020
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
Tramadol may be considered for patients awaiting referral to pain specialist, after initial treatments have failed. See neuropathic pain guidelines below.
Prescribe a short course (2-4 weeks on an acute script) and review at least every 3 months.
PLEASE NOTE:
Standard/Immediate release capsules should be prescribed GENERICALLY
Modified release tablets should be prescribed by BRAND with Marol® being locally preferred
Associated BNF Codes
04. Central Nervous System
04.07.02. Opioid analgesics